Axogen, inc reports 2022 fourth quarter and full-year financial results

Alachua, fla. and tampa, fla., march 14, 2023 (globe newswire) -- axogen, inc. (nasdaq: axgn), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today reported financial results and business highlights for the fourth quarter and full year ended december 31, 2022.

AXGN Ratings Summary

AXGN Quant Ranking